chen qiyu awarded excellent entrepreneur with social responsibility
in the afternoon of november 20, 2010, shanghai academy of social sciences, shanghai food and drug administration and shanghai pharmaceutical profession association jointly held "the first yangtze river delta pharmaceutical csr forum & award ceremony” and nearly 600 guests attended the meeting. the social responsibility of the pharmaceutical enterprises was discussed thoroughly on the meeting, li wuwei, vice chairman of the cppcc, qi moujia, the former director of state food and drug administration, and jiang yiren, standing committee of the cppcc, etc attended the meeting. the award ceremony announced 8 award-winning enterprises and 10 entrepreneurs with outstanding social responsibility. chen qiyu, chairman of fosun pharma and vice president of fosun group were on the list, and won the "yangtze river delta pharmaceutical csr excellent entrepreneur award"
jury pointed out in the award comments that chen qiyu, elected as “2010 china yangtze river delta young business leader”, led fosun pharma, with its corporate spirit “self-improvement, family harmony, career development, social responsibility”, to reward the society with a grateful heart, and actively undertake corporation social responsibility to create a competitive and international medical health industry, and obtain praises of all circles of the society.
during the speech on behalf of the award winning entrepreneurs, chen qiyu expressed that corporation social responsibility was the important part of enterprise development strategy, it was a set of complete system, and was the overall responsibility to the employees, the environment, social development and other aspects. he said, together with his management team and staff, fosun pharma would continue to work hard in the future, to better take corporation social responsibility as a pharmaceutical enterprise.
the other nine entrepreneurs on the list are xu guoxiong, president of shanghai pharmaceuticals holding co., ltd. and chairman of shanghai sine pharmaceutical co., ltd.; zhou bin, vice general manager of china national pharmaceutical group corporation, president and party secretary of shanghai institute of pharmaceutical industry and chairman of shanghai shyndec pharmaceutical co.,ltd.; yang zhongdong, vice general manager of china national biotec group of china national pharmaceutical group corporation; liu hongquan, general manager of sino-swed pharmaceutical corporation ltd.; tu yongrui, chairman and general manager of changzhou the fourth medicine pharmacy co., ltd.; zhou junjie, chairman and general manager of shanghai hutchison pharmaceuticals; mao jianyi, general manager of shanghai zhongxi sunve pharmaceutical co., ltd.; hu linsen; chairman and general manager of shanghai sine promod pharmaceutical co.,ltd.; yan yiyi, chairman general manager and party secretary of zhejiang chengyi pharmaceutical co., ltd.